TAKE16.78

TAKE Limited

· Pharma & Health
₹ CrorePeersVIMTALABSSUVENMcap ₹248 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Non-current Assets
+ Property, Plant & Equipment21.60.00.00.0
+ Other Intangibles8.70.00.00.0
+ Other Non-current Financial Assets3.10.03.73.7
Non-current Financial Assets3.10.03.73.7
+ Deferred Tax Assets2.20.0
+ Other Non-current Assets17.212.98.88.8
Total Non-current Assets52.812.912.512.5
Current Assets
+ Inventories0.80.00.00.0
+ Trade Receivables7.00.00.20.2
+ Cash & Cash Equivalents0.83.40.30.3
+ Other Bank Balances0.10.10.00.0
+ Other Current Financial Assets15.412.318.418.4
Current Financial Assets23.415.718.918.9
+ Other Current Assets11.17.94.94.9
Total Current Assets35.323.623.823.8
Total Assets88.136.536.236.2
Equity
+ Equity Share Capital14.614.614.814.8
+ Other Equity / Reserves-23.55.916.216.2
Equity — Owners of Parent-8.920.531.031.0
+ Minority Interest0.00.00.00.0
Total Equity-8.920.531.031.0
Liabilities
+ Borrowings — Non-current0.80.00.00.0
+ Other Non-current Financial Liab5.80.0
Non-current Financial Liabilities6.60.00.00.0
+ Provisions — Non-current1.2-0.00.00.0
Non-current Liabilities7.8-0.00.00.0
+ Borrowings — Current27.20.00.00.0
+ Trade Payables17.41.51.31.3
+ Other Current Financial Liab18.08.52.72.7
Current Financial Liabilities62.710.04.04.0
+ Provisions — Current0.30.20.20.2
+ Other Current Liabilities26.25.71.01.0
Current Liabilities89.216.05.25.2
Total Liabilities97.016.05.25.2
Total Equity & Liabilities88.136.536.236.2
Trade Payables — MSME split
+ Dues to Micro & Small — Current0.00.00.0
+ Dues to Other Creditors — Current1.51.31.3
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.